Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1
Sex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1
Angela M., et al. 2009. Nat. Med. 15, 955-959
Speaker: Jhen-Yu Ke (柯貞妤) Time:13:00~14:00; Oct. 7, 2009
Commentator: Dr. Yea-Lih Lin (林雅俐 老師) Place: Room 601
Abstract:
Viral infections have been shown to affect women and men differently1. For example, marked differences between gender are reported in HIV-1 disease progression1. Women with untreated HIV tend to develop AIDS faster than men with comparable levels of HIV-1 replication2. In this paper, the authors showed that plasmacytoid dendritic cells (pDCs) with Toll-like receptor 7 (TLR7) derived from women produced significantly more interferon-alpha (IFN-alpha) in response to HIV-1 than pDCs derived from men. IFN-alpha is an immune-stimulating protein resulting in stronger secondary activation of CD8+ T cells. Moreover, this study showed that HIV-infected women who had not yet received treatment had more activated CD8+ T cells than men with comparable amount of virus. The expression of immune activation markers on CD8+ T cells has been shown to independently predict the rate of HIV-1 disease progression3. This enhanced immune activation in women can explain the clinical observation reported previously that women have a higher risk for HIV-1 disease progression than men during chronic infection at a given HIV-1 viral load. Based on this study, regulation of the TLR7 signaling pathway in pDCs might be an alternative approach for treatment of HIV-1.
References:
1. Fish, E.N. et al. 2008. The X-files in immunity: sex-based differences predispose immune responses. Nat. Rev. Immunol. 8, 737-744
2. Farzadegan, H. et al. 1998. Sex differences in HIV-1 viral load and progression to AIDS. Lancet. 352, 1510-1514
3. Fahey, J.L. et al. 1998. Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements. AIDS 12, 1581-1590
